• University of Virginia (B.A., 2005)
  • University of Virginia School of Law (J.D., 2012)


  • District of Columbia and Virginia


Elizabeth W. Chan practices in the Firm’s Complex Litigation, Pharmaceutical Products, and Toxic Torts ‎& Products Liability groups.  She specializes in the defense of complex serial and mass tort ‎litigation — primarily personal injury litigation involving pharmaceutical products — and she ‎has experience with all facets of the litigation process, including pretrial discovery, motions ‎practice, and trial preparation.

Ms. Chan has contributed significantly to motions practice, having researched and drafted case-‎specific dispositive motions as well as motions directed to litigation-wide discovery issues.  She ‎also has significant trial preparation experience, compiling exhibit lists, drafting cross-‎examination outlines, motions in limine, and bench memoranda, and providing and coordinating ‎other trial support as needed.‎

In connection with her defense of pharmaceutical products litigation, Ms. Chan has experience with antitrust and pharmaceutical pricing claims concerning monopolization, price fixing, exclusive dealing arrangements and payments for delay in product marketing in the pharmaceutical industry, and the limits and guidelines for collaborative actions by pharmaceutical competitors.  In her practice, she also deals with issues involving the defense of  pharmaceutical companies and corporate officers relating to FDA, state, and international regulatory compliance investigations and enforcement actions.

Ms. Chan’s pro bono work has included providing legal aid to low-wage workers on insurance ‎issues and tutoring students in math and reading at The SEED Charter School of Washington, ‎D.C.  She also assists in the Firm’s recruiting efforts.

In law school, Ms. Chan was on the Managing Board of The Virginia Journal of Social Policy & ‎the Law.  She is a member of the Firm’s 2011 Summer Associate class.  Ms. Chan is proficient in ‎Mandarin.‎


Bloomberg BNA: Monsanto: Cancer Study Suppression is ‘Scientific Vandalism’

Hollingsworth LLP represents Monsanto in In Re:Roundup Products Liability Litigation in the Northern District of California.